2014-01436. Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Benzonapthyridine Composition and Uses

AGENCY:

Department of the Army, DoD.

ACTION:

Notice.

SUMMARY:

Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/640,832, entitled “Benzonapthyridine Composition and Uses,” filed on April 13, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

ADDRESSES:

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT:

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, [phone]. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), [phone], both at telefax [phone].

SUPPLEMENTARY INFORMATION:

The invention relates to compositions comprising benzonapthridine small molecule immune potentiators (SMIPs) that are capable of stimulating or Modulating an immune response in a subject that has had pre- or post- exposure to a pathogen such as hemorrhagic fever virus.

Brenda S. Bowen,

Army Federal Register Liaison Officer.